Connections between various trigger factors and the RIP1/RIP3 signaling pathway involved in necroptosis

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7069-7074

  Zhang, Yuan Yuan ^a   Liu, Hao ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Fas; MLKL complex; Necroptosis; RIP1 RIP3 necrosome; TNFR; TRAILR

Indexed keywords

AGFG1 PROTEIN, HUMAN; NUCLEOPORIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN; RNA BINDING PROTEIN;

DISEASES; HUMAN; METABOLISM; NECROSIS; SIGNAL TRANSDUCTION;

DISEASE; HUMANS; NECROSIS; NUCLEAR PORE COMPLEX PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84893423815     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7069     Document Type: Short Survey

References (65)

1. Alexopoulou L, Holt AC, Medzhitov R, et al (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature, 413, 732-8.
2. Andera L (2009). Signaling activated by the death receptors of the TNFR family. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 153, 173-80.
3. Bao L, Li Y, Deng SX, et al (2006). Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. J Biol Chem, 281, 33635-49.
4. Budd RC, Yeh WCTschopp J (2006). cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol, 6, 196-204.
5. Chan FKBaehrecke EH (2012). RIP3 finds partners in crime. Cell, 148, 17-8.
6. Chan FK, Shisler J, Bixby JG, et al (2003). A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem, 278, 51613-21.
7. Cho YS, Challa S, Moquin D, et al (2009). Phosphorylationdriven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell, 137, 1112-23.
8. Degterev A, Huang Z, Boyce M, et al (2005). Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol, 1, 112-9.
9. Feoktistova M, Geserick P, Kellert B, et al (2011). cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell, 43, 449-63.
10. Festjens N, Vanden Berghe T, Cornelis S, et al (2007). RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ, 14, 400-10.
11. Fricker N, Beaudouin J, Richter P, et al (2010). Model-based dissection of CD95 signaling dynamics reveals both a proand antiapoptotic role of c-FLIPL. J Cell Biol, 190, 377-89.
12. Galluzzi L, Vanden Berghe T, Vanlangenakker N, et al (2011). Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol, 289, 1-35.
13. Golks A, Brenner D, Fritsch C, et al (2005). c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem, 280, 14507-13.
14. Han W, Li L, Qiu S, et al (2007). Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther, 6, 1641-9.
15. He S, Liang Y, Shao F, et al (2011). Toll-like receptors activate programmed necrosis in macrophages through a receptorinteracting kinase-3-mediated pathway. Proc Natl Acad Sci U S A, 108, 20054-9.
16. He S, Wang L, Miao L, et al (2009). Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell, 137, 1100-11.
17. Hitomi J, Christofferson DE, Ng A, et al (2008). Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell, 135, 1311-23.
18. Holen I, Croucher PI, Hamdy FC, et al (2002). Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells. Cancer Res, 62, 1619-23.
19. Holler N, Zaru R, Micheau O, et al (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol, 1, 489-95.
20. Hoshino K, Takeuchi O, Kawai T, et al (1999). Cutting edge: Tolllike receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol, 162, 3749-52.
21. Hsu TS, Yang PM, Tsai JS, et al (2009). Attenuation of cadmiuminduced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicol Appl Pharmacol, 235, 153-62.
22. Hymowitz SG, Christinger HW, Fuh G, et al (1999). Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell, 4, 563-71.
23. Jain MV, Paczulla AM, Klonisch T, et al (2013). Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. J Cell Mol Med, 17, 12-29.
24. Kaiser WJ, Sridharan H, Huang C, et al (2013). Toll-like Receptor 3-mediated necrosis via TRIF, RIP3 and MLKL. J Biol Chem.
25. Kemp TJ, Kim JS, Crist SA, et al (2003). Induction of necrotic tumor cell death by TRAIL/Apo-2L. Apoptosis, 8, 587-99.
26. Kim JW, Choi EJJoe CO (2000). Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene, 19, 4491-9.
27. Kim S, Dayani L, Rosenberg PA, et al (2010). RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. Int J Physiol Pathophysiol Pharmacol, 2, 137-47.
28. Krammer PH (2000). CD95's deadly mission in the immune system. Nature, 407, 789-95.
29. Krueger A, Schmitz I, Baumann S, et al (2001). Cellular FLICEinhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem, 276, 20633-40.
30. Kumar H, Kawai TAkira S (2011). Pathogen recognition by the innate immune system. Int Rev Immunol, 30, 16-34.
31. Laird MD, Wakade C, Alleyne CH, Jr., et al (2008). Hemininduced necroptosis involves glutathione depletion in mouse astrocytes. Free Radic Biol Med, 45, 1103-14.
32. Laster SM, Wood JGGooding LR (1988). Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol, 141, 2629-34.
33. Lavrik INKrammer PH (2012). Regulation of CD95/Fas signaling at the DISC. Cell Death Differ, 19, 36-41.
34. Li J, McQuade T, Siemer AB, et al (2012). The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell, 150, 339-50.
35. Li Y, Yang X, Ma C, et al (2008). Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neurosci Lett, 447, 120-3.
36. Lin Y, Choksi S, Shen HM, et al (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptorinteracting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem, 279, 10822-8.
37. Ma Y, Temkin V, Liu H, et al (2005). NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein. J Biol Chem, 280, 41827-34.
38. Mahalingam D, Szegezdi E, Keane M, et al (2009). TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev, 35, 280-8.
39. Marsters SA, Sheridan JP, Pitti RM, et al (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol, 7, 1003-6.
40. Meurette O, Huc L, Rebillard A, et al (2005). TRAIL (TNFrelated apoptosis-inducing ligand) induces necrosis-like cell death in tumor cells at acidic extracellular pH. Ann N Y Acad Sci, 1056, 379-87.
41. Meurette O, Rebillard A, Huc L, et al (2007). TRAIL induces receptor-interacting protein 1-dependent and caspasedependent necrosis-like cell death under acidic extracellular conditions. Cancer Res, 67, 218-26.
42. Micheau OTschopp J (2003). Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell, 114, 181-90.
43. Moquin DChan FK (2010). The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci, 35, 434-41.
44. O'Donnell MA, Legarda-Addison D, Skountzos P, et al (2007). Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol, 17, 418-24.
45. O'Donnell MA, Perez-Jimenez E, Oberst A, et al (2011). Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol, 13, 1437-42.
46. Oberst A, Dillon CP, Weinlich R, et al (2011). Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature, 471, 363-7.
47. Oettgen HF, Carswell EA, Kassel RL, et al (1980). Endotoxininduced tumor necrosis factor. Recent Results Cancer Res, 75, 207-12.
48. Pan G, Ni J, Wei YF, et al (1997a). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science, 277, 815-8.
49. Pan G, O'Rourke K, Chinnaiyan AM, et al (1997b). The receptor for the cytotoxic ligand TRAIL. Science, 276, 111-3.
50. Poltorak A, He X, Smirnova I, et al (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-8.
51. Sheridan JP, Marsters SA, Pitti RM, et al (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277, 818-21.
52. Sun L, Wang H, Wang Z, et al (2012). Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell, 148, 213-27.
53. Tenev T, Bianchi K, Darding M, et al (2011). The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell, 43, 432-48.
54. Upton JW, Kaiser WJMocarski ES (2010). Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe, 7, 302-13.
55. Van Herreweghe F, Festjens N, Declercq W, et al (2010). Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci, 67, 1567-79.
56. Vandenabeele P, Galluzzi L, Vanden Berghe T, et al (2010). Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol, 11, 700-14.
57. Vanlangenakker N, Vanden Berghe T, Bogaert P, et al (2011). cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ, 18, 656-65.
58. Vercammen D, Brouckaert G, Denecker G, et al (1998). Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med, 188, 919-30.
59. Vercammen D, Vandenabeele P, Beyaert R, et al (1997). Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine, 9, 801-8.
60. Wang L, Du FWang X (2008). TNF-alpha induces two distinct caspase-8 activation pathways. Cell, 133, 693-703.
61. Wang Z, Jiang H, Chen S, et al (2012). The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell, 148, 228-43.
62. Wu W, Liu PLi J (2012). Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol, 82, 249-58.
63. Wyllie AH, Kerr JFCurrie AR (1980). Cell death: the significance of apoptosis. Int Rev Cytol, 68, 251-306.
64. Xu X, Chua CC, Kong J, et al (2007). Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem, 103, 2004-14.
65. Zhang QL, Niu Q, Ji XL, et al (2008). Is necroptosis a death pathway in aluminum-induced neuroblastoma cell demise? Int J Immunopathol Pharmacol, 21, 787-96.